Liver function parameters in asymptomatic smokers – A cross-sectional study

Background: Smoking remains the single most common cause of preventable deaths. The liver is affected by the process of smoking through various inflammatory pathways. This will lead to aggravation of pathogenic impact on the liver tissue. The present study was undertaken to determine the liver funct...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:National journal of physiology, pharmacy and pharmacology pharmacy and pharmacology, 2024, Vol.14 (10), p.1-1997
Hauptverfasser: P, Fathima, KP, Kalyanikutty
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1997
container_issue 10
container_start_page 1
container_title National journal of physiology, pharmacy and pharmacology
container_volume 14
creator P, Fathima
KP, Kalyanikutty
description Background: Smoking remains the single most common cause of preventable deaths. The liver is affected by the process of smoking through various inflammatory pathways. This will lead to aggravation of pathogenic impact on the liver tissue. The present study was undertaken to determine the liver function parameters in cigarette smokers. Aims and Objectives: The objective was to estimate and compare the parameters of liver function – alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), total bilirubin, total protein, albumin, and globulin in asymptomatic male smokers and non-smokers of the age group 25–50 years in the above two groups. Materials and Methods: A cross-sectional comparative study was conducted on 60 males with 30 smokers and 30 non-smokers of the age group 25–50 years. All the subjects who have satisfied the inclusion and exclusion criteria were incorporated in the study. Informed consent was taken before the conduct of the study. The participants were selected in a consecutive manner till the sample size was achieved. AST, ALT, ALP, total bilirubin, total protein, and albumin were estimated using ERBA EM 360 fully automatic analyzer. The difference between the total protein and albumin was used to calculate the level of globulin. The Statistical Package for the Social Sciences version 18 was used for data analysis. Results: The mean values of AST, ALT, and ALP were significantly elevated in smokers when compared to non-smokers. The mean values of total bilirubin, total protein, albumin, and globulin were significantly decreased in smokers. Conclusion: Smoking leads to the development of hepatic damage which increases the intensity of complications. The study reveals the importance of screening asymptomatic smokers for liver function parameters to avoid complications of hepatic diseases hence improving the quality of life.
doi_str_mv 10.5455/njppp.2024.14.03144202403052024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3104585997</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3104585997</sourcerecordid><originalsourceid>FETCH-LOGICAL-c847-7870d781f96aaf245c59caa00158b73fd7b9dfc43de848c0d5ae5daf0bce71c13</originalsourceid><addsrcrecordid>eNplkMtOwzAQRS0EEhX0HyyxYJUwftXOClUVL6mITfeW64eU0iTGTpC64x_4Q76EpGXHbO7M6M7o6iB0S6AUXIi7dhdjLClQXhJeAiOcTwMwEJOeoRmljBSMwuJ87Ect-ELSSzTPeQdjVZyMjhl6XdefPuEwtLavuxZHk0zje58yrlts8qGJfdeYvrY4N937tP_5-sZLbFOXc5H98czsce4Hd7hGF8Hss5__6RXaPD5sVs_F-u3pZbVcF1ZxWUglwUlFQrUwJlAurKisMQBEqK1kwclt5YLlzHnFlQUnjBfOBNhaL4kl7ArdnN7G1H0MPvd61w1pTJE1I8CFElUlR9f9yXWMmnzQMdWNSQdNQE8U9ZGinoBpwvU_iuwXY0FpWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3104585997</pqid></control><display><type>article</type><title>Liver function parameters in asymptomatic smokers – A cross-sectional study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>P, Fathima ; KP, Kalyanikutty</creator><creatorcontrib>P, Fathima ; KP, Kalyanikutty</creatorcontrib><description>Background: Smoking remains the single most common cause of preventable deaths. The liver is affected by the process of smoking through various inflammatory pathways. This will lead to aggravation of pathogenic impact on the liver tissue. The present study was undertaken to determine the liver function parameters in cigarette smokers. Aims and Objectives: The objective was to estimate and compare the parameters of liver function – alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), total bilirubin, total protein, albumin, and globulin in asymptomatic male smokers and non-smokers of the age group 25–50 years in the above two groups. Materials and Methods: A cross-sectional comparative study was conducted on 60 males with 30 smokers and 30 non-smokers of the age group 25–50 years. All the subjects who have satisfied the inclusion and exclusion criteria were incorporated in the study. Informed consent was taken before the conduct of the study. The participants were selected in a consecutive manner till the sample size was achieved. AST, ALT, ALP, total bilirubin, total protein, and albumin were estimated using ERBA EM 360 fully automatic analyzer. The difference between the total protein and albumin was used to calculate the level of globulin. The Statistical Package for the Social Sciences version 18 was used for data analysis. Results: The mean values of AST, ALT, and ALP were significantly elevated in smokers when compared to non-smokers. The mean values of total bilirubin, total protein, albumin, and globulin were significantly decreased in smokers. Conclusion: Smoking leads to the development of hepatic damage which increases the intensity of complications. The study reveals the importance of screening asymptomatic smokers for liver function parameters to avoid complications of hepatic diseases hence improving the quality of life.</description><identifier>ISSN: 2320-4672</identifier><identifier>EISSN: 2231-3206</identifier><identifier>DOI: 10.5455/njppp.2024.14.03144202403052024</identifier><language>eng</language><publisher>Surat: Association of Physiologists, Pharmacists &amp; Pharmacologists</publisher><subject>Age groups ; Asymptomatic ; Cigarettes ; Cross-sectional studies ; Cytokines ; Free radicals ; Gallbladder diseases ; Hypoxia ; Lipid peroxidation ; Liver cirrhosis ; Liver diseases ; Males ; Nitrogen dioxide ; Phosphatase ; Proteins ; Quality of life ; Respiratory system ; Smoking</subject><ispartof>National journal of physiology, pharmacy and pharmacology, 2024, Vol.14 (10), p.1-1997</ispartof><rights>2024. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>P, Fathima</creatorcontrib><creatorcontrib>KP, Kalyanikutty</creatorcontrib><title>Liver function parameters in asymptomatic smokers – A cross-sectional study</title><title>National journal of physiology, pharmacy and pharmacology</title><description>Background: Smoking remains the single most common cause of preventable deaths. The liver is affected by the process of smoking through various inflammatory pathways. This will lead to aggravation of pathogenic impact on the liver tissue. The present study was undertaken to determine the liver function parameters in cigarette smokers. Aims and Objectives: The objective was to estimate and compare the parameters of liver function – alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), total bilirubin, total protein, albumin, and globulin in asymptomatic male smokers and non-smokers of the age group 25–50 years in the above two groups. Materials and Methods: A cross-sectional comparative study was conducted on 60 males with 30 smokers and 30 non-smokers of the age group 25–50 years. All the subjects who have satisfied the inclusion and exclusion criteria were incorporated in the study. Informed consent was taken before the conduct of the study. The participants were selected in a consecutive manner till the sample size was achieved. AST, ALT, ALP, total bilirubin, total protein, and albumin were estimated using ERBA EM 360 fully automatic analyzer. The difference between the total protein and albumin was used to calculate the level of globulin. The Statistical Package for the Social Sciences version 18 was used for data analysis. Results: The mean values of AST, ALT, and ALP were significantly elevated in smokers when compared to non-smokers. The mean values of total bilirubin, total protein, albumin, and globulin were significantly decreased in smokers. Conclusion: Smoking leads to the development of hepatic damage which increases the intensity of complications. The study reveals the importance of screening asymptomatic smokers for liver function parameters to avoid complications of hepatic diseases hence improving the quality of life.</description><subject>Age groups</subject><subject>Asymptomatic</subject><subject>Cigarettes</subject><subject>Cross-sectional studies</subject><subject>Cytokines</subject><subject>Free radicals</subject><subject>Gallbladder diseases</subject><subject>Hypoxia</subject><subject>Lipid peroxidation</subject><subject>Liver cirrhosis</subject><subject>Liver diseases</subject><subject>Males</subject><subject>Nitrogen dioxide</subject><subject>Phosphatase</subject><subject>Proteins</subject><subject>Quality of life</subject><subject>Respiratory system</subject><subject>Smoking</subject><issn>2320-4672</issn><issn>2231-3206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNplkMtOwzAQRS0EEhX0HyyxYJUwftXOClUVL6mITfeW64eU0iTGTpC64x_4Q76EpGXHbO7M6M7o6iB0S6AUXIi7dhdjLClQXhJeAiOcTwMwEJOeoRmljBSMwuJ87Ect-ELSSzTPeQdjVZyMjhl6XdefPuEwtLavuxZHk0zje58yrlts8qGJfdeYvrY4N937tP_5-sZLbFOXc5H98czsce4Hd7hGF8Hss5__6RXaPD5sVs_F-u3pZbVcF1ZxWUglwUlFQrUwJlAurKisMQBEqK1kwclt5YLlzHnFlQUnjBfOBNhaL4kl7ArdnN7G1H0MPvd61w1pTJE1I8CFElUlR9f9yXWMmnzQMdWNSQdNQE8U9ZGinoBpwvU_iuwXY0FpWA</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>P, Fathima</creator><creator>KP, Kalyanikutty</creator><general>Association of Physiologists, Pharmacists &amp; Pharmacologists</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2024</creationdate><title>Liver function parameters in asymptomatic smokers – A cross-sectional study</title><author>P, Fathima ; KP, Kalyanikutty</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c847-7870d781f96aaf245c59caa00158b73fd7b9dfc43de848c0d5ae5daf0bce71c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age groups</topic><topic>Asymptomatic</topic><topic>Cigarettes</topic><topic>Cross-sectional studies</topic><topic>Cytokines</topic><topic>Free radicals</topic><topic>Gallbladder diseases</topic><topic>Hypoxia</topic><topic>Lipid peroxidation</topic><topic>Liver cirrhosis</topic><topic>Liver diseases</topic><topic>Males</topic><topic>Nitrogen dioxide</topic><topic>Phosphatase</topic><topic>Proteins</topic><topic>Quality of life</topic><topic>Respiratory system</topic><topic>Smoking</topic><toplevel>online_resources</toplevel><creatorcontrib>P, Fathima</creatorcontrib><creatorcontrib>KP, Kalyanikutty</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science &amp; Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>National journal of physiology, pharmacy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>P, Fathima</au><au>KP, Kalyanikutty</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liver function parameters in asymptomatic smokers – A cross-sectional study</atitle><jtitle>National journal of physiology, pharmacy and pharmacology</jtitle><date>2024</date><risdate>2024</risdate><volume>14</volume><issue>10</issue><spage>1</spage><epage>1997</epage><pages>1-1997</pages><issn>2320-4672</issn><eissn>2231-3206</eissn><abstract>Background: Smoking remains the single most common cause of preventable deaths. The liver is affected by the process of smoking through various inflammatory pathways. This will lead to aggravation of pathogenic impact on the liver tissue. The present study was undertaken to determine the liver function parameters in cigarette smokers. Aims and Objectives: The objective was to estimate and compare the parameters of liver function – alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), total bilirubin, total protein, albumin, and globulin in asymptomatic male smokers and non-smokers of the age group 25–50 years in the above two groups. Materials and Methods: A cross-sectional comparative study was conducted on 60 males with 30 smokers and 30 non-smokers of the age group 25–50 years. All the subjects who have satisfied the inclusion and exclusion criteria were incorporated in the study. Informed consent was taken before the conduct of the study. The participants were selected in a consecutive manner till the sample size was achieved. AST, ALT, ALP, total bilirubin, total protein, and albumin were estimated using ERBA EM 360 fully automatic analyzer. The difference between the total protein and albumin was used to calculate the level of globulin. The Statistical Package for the Social Sciences version 18 was used for data analysis. Results: The mean values of AST, ALT, and ALP were significantly elevated in smokers when compared to non-smokers. The mean values of total bilirubin, total protein, albumin, and globulin were significantly decreased in smokers. Conclusion: Smoking leads to the development of hepatic damage which increases the intensity of complications. The study reveals the importance of screening asymptomatic smokers for liver function parameters to avoid complications of hepatic diseases hence improving the quality of life.</abstract><cop>Surat</cop><pub>Association of Physiologists, Pharmacists &amp; Pharmacologists</pub><doi>10.5455/njppp.2024.14.03144202403052024</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2320-4672
ispartof National journal of physiology, pharmacy and pharmacology, 2024, Vol.14 (10), p.1-1997
issn 2320-4672
2231-3206
language eng
recordid cdi_proquest_journals_3104585997
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Age groups
Asymptomatic
Cigarettes
Cross-sectional studies
Cytokines
Free radicals
Gallbladder diseases
Hypoxia
Lipid peroxidation
Liver cirrhosis
Liver diseases
Males
Nitrogen dioxide
Phosphatase
Proteins
Quality of life
Respiratory system
Smoking
title Liver function parameters in asymptomatic smokers – A cross-sectional study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T18%3A27%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liver%20function%20parameters%20in%20asymptomatic%20smokers%20%E2%80%93%20A%20cross-sectional%20study&rft.jtitle=National%20journal%20of%20physiology,%20pharmacy%20and%20pharmacology&rft.au=P,%20Fathima&rft.date=2024&rft.volume=14&rft.issue=10&rft.spage=1&rft.epage=1997&rft.pages=1-1997&rft.issn=2320-4672&rft.eissn=2231-3206&rft_id=info:doi/10.5455/njppp.2024.14.03144202403052024&rft_dat=%3Cproquest_cross%3E3104585997%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3104585997&rft_id=info:pmid/&rfr_iscdi=true